BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 15636691)

  • 1. Multifocal neuropathy due to plasma cell infiltration of peripheral nerves in multiple myeloma.
    Denier C; Lozeron P; Adams D; Decaudin D; Isnard-Grivaux F; Lacroix C; Said G
    Neurology; 2006 Mar; 66(6):917-8. PubMed ID: 16567713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurological aspects of multiple myeloma and related disorders.
    Dispenzieri A; Kyle RA
    Best Pract Res Clin Haematol; 2005; 18(4):673-88. PubMed ID: 16026744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonsystemic vasculitic neuropathy in a patient with IgG-monoclonal gammopathy of undetermined significance: A case report.
    Kinno R; Osakabe Y; Takahashi S; Kurokawa S; Owan Y; Ono K; Baba Y
    Medicine (Baltimore); 2020 Jan; 99(5):e19036. PubMed ID: 32000451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Managing treatment-related peripheral neuropathy in patients with multiple myeloma.
    Grammatico S; Cesini L; Petrucci MT
    Blood Lymphat Cancer; 2016; 6():37-47. PubMed ID: 31360079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subclinical pretreatment sensory deficits appear to predict the development of pain and numbness in patients with multiple myeloma undergoing chemotherapy.
    Vichaya EG; Wang XS; Boyette-Davis JA; Mendoza TR; He Z; Thomas SK; Shah N; Williams LA; Cleeland CS; Dougherty PM
    Cancer Chemother Pharmacol; 2013 Jun; 71(6):1531-40. PubMed ID: 23543296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does my patient with a serum monoclonal spike have multiple myeloma?
    Bianchi G; Ghobrial IM
    Hematol Oncol Clin North Am; 2012 Apr; 26(2):383-93, ix. PubMed ID: 22463833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral neuropathy and new treatments for multiple myeloma: background and practical recommendations.
    Mohty B; El-Cheikh J; Yakoub-Agha I; Moreau P; Harousseau JL; Mohty M
    Haematologica; 2010 Feb; 95(2):311-9. PubMed ID: 20139393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paraproteinemic neuropathies.
    Vital A
    Brain Pathol; 2001 Oct; 11(4):399-407. PubMed ID: 11556684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurologic complications of plasma cell disorders.
    Drappatz J; Batchelor T
    Clin Lymphoma; 2004 Dec; 5(3):163-71. PubMed ID: 15636691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review of peripheral neuropathy in plasma cell disorders.
    Silberman J; Lonial S
    Hematol Oncol; 2008 Jun; 26(2):55-65. PubMed ID: 18324611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurologic aspects of plasma cell disorders.
    Sobol U; Stiff P
    Handb Clin Neurol; 2014; 120():1083-99. PubMed ID: 24365373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neurologic manifestations of monoclonal gammapathies].
    Uldry PA; Steck AJ; Regli F
    Schweiz Med Wochenschr; 1984 Nov; 114(47):1678-85. PubMed ID: 6096963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polyneuropathy in paraproteinaemia.
    Meier C
    J Neurol; 1985; 232(4):204-14. PubMed ID: 2995596
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.